The global transient ischemic attack market is anticipated to grow at a considerable CAGR of 6.1% during the forecast period (2021-2027). The rising pervasiveness of cardiovascular diseases is one of the prime factors affecting and driving the market. According to the World Health Organisation (WHO) around 17.9 million people across the globe die due to cardiovascular diseases (CVD) every year. Moreover, Blood pressure is one of the important factors resulting in the increasing risk of transient ischemic attack and ischemic stroke due to their strong associations, high prevalence, and the possibility for intervention in the people.
To Request a Sample of our Report on Transient Ischemic Attack Market: https://www.omrglobal.com/request-sample/transient-ischemic-attack-market
Further, to gain on the opportunity key players operating in the global transient ischemic attack market had been adopting an expansion strategy. For instance, in July 2020, Daiichi Sankyo Co. Ltd., had put forward the results of Phase 3 of its prasugrel antiplatelet agent, with regards to patients suffered from thrombotic stroke. This study was conducted in order to check the efficacy and safety in 234 thrombotic stroke patients for recurrence of ischemic stroke.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
· By Diagnosis
· By Treatment
· By End-Users
• Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
· Competitive Landscape- Abbott, Cardinal Health, electroCore, Inc., Medtronic, Siemens and Healthcare Pvt. Ltd.
(Get 15% Discount on Buying this Report)
A full Report of Transient Ischemic Attack Market is Available at: https://www.omrglobal.com/industry-reports/transient-ischemic-attack-market
Global Transient Ischemic Attack Market
By Diagnosis
• Carotid Ultrasonography
• CT Scan and CT Angiography Scan
• MRI Scan and MR Angiography
• Echocardiography
• Electrocardiogram
• Other
By Treatment
• Medication
• Surgery
• Angioplasty
By End-Users
• Hospital & Clinics
• Research Institutes
• Diagnostic Centers
Global Transient Ischemic Attack Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Company Profiles
· Abbott
· Acticor Biotech SAS
· AstraZeneca
· Bayer AG
· Boston Scientific Corp.
· Cardinal Health.
· DAIICHI SANKYO CO. LTD.
· electroCore, Inc.
· Lilly
· General Electric
· LivaNova PLC
· Medtronic
· Merck KgaA
· Novartis AG
· Novo Nordisk A/S
· Pfizer Inc.
· Sanofi
· Siemens Healthcare Pvt. Ltd.
· Stryker
· Terumo Corp.
· Zocere, Inc.
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
